Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...

As of 2020, more than 1.9 million people around the world were diagnosed with colorectal cancer each year, making it the third most common cancer globally. Now, a new study presented at the 2025 ...

Please provide your email address to receive an email when new articles are posted on . Patients with stage III or high-risk stage II colon cancer in a structured exercise program had 28% lower risk ...

Colon, lung, and liver cancers are among the most prevalent and lethal cancers globally. Despite advancements in treatment, these cancers continue to pose significant challenges due to high mortality ...

SAN ANTONIO, Texas (Ivanhoe Newswire) - Colorectal cancer often spreads to the liver, requiring prolonged chemotherapy. But now, doctors are turning to hepatic artery infusion. This therapy delivers ...

Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients The following represents disclosure information provided by authors of this manuscript. All ...

Neoadjuvant therapy for patients with metastatic colon cancer with single-organ liver or lung lesions was associated with improved overall survival in comparison with adjuvant therapy, according to ...

An interview with Dr. Nancy Baxter from the University of Melbourne in Melbourne, Australia, and Dr. Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston, MA, co-chairs on “Adjuvant Therapy ...

The identification of rare genomic alterations in patients with colorectal cancer gives oncologists the opportunity to treat patients who otherwise might not have many options. When Mia Balko, 48, ...